Purinethol

Active Ingredient(s): Mercaptopurine, 6-MP
FDA Approved: * September 11, 1953
Pharm Company: * TEVA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Purinethol Overview

Mercaptopurine (6-MP), sold under the brand name Purinethol among others, is a medication used for cancer and autoimmune diseases.[1] Specifically it is used to treat acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.[1][2] For ALL it is generally used with methotrexate. It is taken by mouth.[1] Common side effects include bone marrow suppression, liver toxicity, vomiting, and loss of appetite. Other serious side effects include an incre...

Read more Purinethol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mercaptopurine

Recent Purinethol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mercaptopurine, 6-MP
  • Suspension: 20mg/ml
  • Tablet: 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Purinethol: (1 result)

Sorted by National Drug Code
  • 57844-522 Purinethol 50 mg Oral Tablet by Gate Pharmaceuticals

Other drugs which contain Mercaptopurine, 6-MP or a similar ingredient: (3 results)